A mobile health platform to remotely manage cardiovascular disease, cancer, neurological conditions
A UK digital health company is validating a mobile health platform that is more patient-centric but approved by subject matter experts and working alongside leading clinicians. It allows for multiple users and multiple languages at all times. Licensing is being sought with pharma, biotech, medtech companies in vascular, cancer, neurological disease. At the same time, partners’ clinical pathways can be enhanced and validated quickly in the UK under a technical cooperation.